پنجشنبه 1 آذر 1403
[Archive]
دوره 29، شماره 136 - ( 6-1400 )
جلد 29 شماره 136 صفحات 308-302 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rezabeigi-Davarani E, Bokaie S, Mashayekhi V, Sharifi L, Faryabi R, Alian Samakkhah S, et al . Epidemiological and Clinical Characteristics of COVID-19 Patients Studied by Jiroft University of Medical Sciences: Southeast of Iran. J Adv Med Biomed Res 2021; 29 (136) :302-308
URL: http://journal.zums.ac.ir/article-1-6250-fa.html
URL: http://journal.zums.ac.ir/article-1-6250-fa.html
Epidemiological and Clinical Characteristics of COVID-19 Patients Studied by Jiroft University of Medical Sciences: Southeast of Iran. Journal of Advances in Medical and Biomedical Research. 1400; 29 (136) :302-308
چکیده: (133820 مشاهده)
Background and Objective: The behavior of COVID-19, clinical symptoms, and mortality rate are not the same in different regions. Due to lack of knowledge about the cited issues, we aimed to investigate the clinical symptoms, case fatality rate, and some risk factors of COVID-19.
Materials and Methods: This longitudinal study was started from the late February 2020 and lasted to the mid-July 2020 in Jiroft, Kerman province, Iran. The course of the disease, clinical signs and symptoms, underlying diseases, patients' exposure history, travel history, adherence to health instructions, and the fatality rate of the disease were evaluated in the patients. The descriptive statistics and frequency were analyzed in different groups using IBM SPSS statistics version 20.
Results: In this study, 2977 definitive cases of COVID-19 were detected using RT-PCR test. The frequent clinical symptoms were fever (45.2%), body aches and bruises (38.8%), and cough (36.4%), respectively. The fatality rate of the disease was 4%. Evaluation of the patients’ exposure history showed that almost 50% of the cases had no exposure. Among the studied individuals, 33% had the history of exposure to a definite COVID-19 case.
Conclusion: Personal hygiene, social distancing, and use of face mask are of great importance in reducing the disease morbidity and mortality. Public awareness about COVID-19 should also be increased, especially in the elderly individuals with the history of underlying and chronic diseases.
نوع مطالعه: مقاله پژوهشی |
موضوع مقاله:
Epidemiologic studies
دریافت: 1399/7/14 | پذیرش: 1399/10/24 | انتشار: 1400/1/15
دریافت: 1399/7/14 | پذیرش: 1399/10/24 | انتشار: 1400/1/15
فهرست منابع
1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13. [DOI:10.1016/S0140-6736(20)30211-7]
2. Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of 2019‐nCoV in Italy: Where they come from? J Med Virol. 2020;92(5):518-21. [DOI:10.1002/jmv.25699]
3. Zhao D, Yao F, Wang L, et al. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clin Infect Dis. 2020. ciaa247. [DOI:10.1093/cid/ciaa247]
4. Akbari A, Emami A, Javanmardi F, Pirbonyeh N, Fadakar N. Early epidemiological analysis of COVID-19: first report from South of Iran. 2020. [DOI:10.21203/rs.3.rs-19915/v1]
5. Shahnazi H, Ahmadi-Livani M, Pahlavanzadeh B, Rajabi A, Hamrah MS, Charkazi A. Assessing preventive health behaviors from COVID-19: a cross sectional study with health belief model in Golestan Province, Northern of Iran. Infect Dis Poverty. 2020;9(1):1-9. [DOI:10.1186/s40249-020-00776-2]
6. Devi S. COVID-19 resurgence in Iran. Lancet (London, England). 2020;395(10241):1896. [DOI:10.1016/S0140-6736(20)31407-0]
7. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020:105924. [DOI:10.1016/j.ijantimicag.2020.105924]
8. Li X, Zai J, Zhao Q, et al. Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2. J Med Virol. 2020;92(6):602-11. [DOI:10.1002/jmv.25731]
9. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74. [DOI:10.1016/S0140-6736(20)30251-8]
10. Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirol. 2018;23(2):130-7. [DOI:10.1111/resp.13196]
11. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New Eng J Med. 2012;367(19):1814-20. [DOI:10.1056/NEJMoa1211721]
12. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trend Microb. 2016;24(6):490-502. [DOI:10.1016/j.tim.2016.03.003]
13. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401-2. [DOI:10.1002/jmv.25678]
14. Nikpouraghdam M, Farahani AJ, Alishiri G, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol. 2020. 127: 104378 [DOI:10.1016/j.jcv.2020.104378]
15. Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. The Lancet Infectious Diseases. 2020. [DOI:10.1016/S1473-3099(20)30287-5]
16. Araban M, Karimy M, Mesri M, Armoon B, Koohestani HR, Azani H. Epidemiological, clinical characteristics of coronavirus-infected disease (COVID-19) among sample of Iranian community: funding from survey in central of Iran. 2020. [DOI:10.21203/rs.3.rs-32797/v1]
17. Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus. 2020;12(3): e7355 [DOI:10.7759/cureus.7355]
18. Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. J Med Virol. 2020;92(6):568-76. [DOI:10.1002/jmv.25748]
19. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Statpearls [internet]: StatPearls Publishing; 2020.
20. Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW. Potential neurological symptoms of COVID-19. Therap Adv Neurol Disorder. 2020;13:1756286420917830. [DOI:10.1177/1756286420917830]
21. D'Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management. Clin Gastroenterol Hepatol. 2020. 18(8):1663-72 [DOI:10.1016/j.cgh.2020.04.001]
22. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. New Eng J Medicine. 2020. 382(10):929-36 [DOI:10.1056/NEJMoa2001191]
23. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020.
24. Kanne JP. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiol Soc North Am. 2020. 295(1):16-17 [DOI:10.1148/radiol.2020200241]
25. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020. 71(15):769-77 [DOI:10.1093/cid/ciaa272]
26. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5]
27. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. [DOI:10.1001/jama.2020.1585]
28. Giangreco G. Case fatality rate analysis of Italian COVID‐19 outbreak. J Med Virol. 2020. ciaa272 [DOI:10.1002/jmv.25894]
29. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of COVID-19 in New York city. N Eng J Med. 2020. 382(24):2372-74 [DOI:10.1056/NEJMc2010419]
30. Gordis L. The epidemiologic approach to evaluating screening programs. Epidemiology (4th edition) Saunders. 2009;311.
31. Zhao XY, Xu XX, Yin HS, et al. Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. BMC Infect Dis. 2020;20:1-8. [DOI:10.1186/s12879-020-05010-w]
32. Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020;8(4):e20. [DOI:10.1016/S2213-2600(20)30117-X]
33. Adhikari SP, Meng S, Wu YJ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Pover. 2020;9(1):1-12. [DOI:10.1186/s40249-020-00646-x]
34. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020:1-6. [DOI:10.1007/s12098-020-03263-6]
35. Yao X, Li T, He Z, et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Chinese J Pathol. 2020;49:E009-E.
36. Chen X, Ran L, Liu Q, Hu Q, Du X, Tan X. Hand hygiene, mask-wearing behaviors and its associated factors during the COVID-19 epidemic: A cross-sectional study among primary school students in Wuhan, China. Int J Environment Res Pub Health. 2020;17(8):2893. [DOI:10.3390/ijerph17082893]
37. Ha KM. The principle of distance during COVID-19 outbreak in Korea. Int Microbiol. 2020;23(4):641-3. [DOI:10.1007/s10123-020-00138-w]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
